XML 59 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1
INVESTMENTS - Narrative (Details) - USD ($)
$ in Thousands, shares in Millions
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 02, 2016
Jul. 26, 2016
Jan. 28, 2016
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Jun. 30, 2016
Dec. 01, 2016
Schedule of Equity Method Investments [Line Items]                    
One-time gain related to remeasurement       $ 0 $ 0   $ 204,833 $ 0    
Innovatix                    
Schedule of Equity Method Investments [Line Items]                    
Equity method investment (as a percent)                   50.00%
Ownership interest acquired (as a percent) 50.00%                  
One-time gain related to remeasurement $ 204,800         $ 204,800        
PSCI | FFF                    
Schedule of Equity Method Investments [Line Items]                    
Ownership interest through subsidiary (as a percent)   49.00%                
Cash portion of acquisition price   $ 65,700                
Initial investment   87,100                
Consideration in the form of net fair value of put and call rights   15,400                
Deferred taxes attributed to fair value of put and call rights   $ 6,000                
PSCI | Class B Membership Interests | Bloodbuy                    
Schedule of Equity Method Investments [Line Items]                    
Ownership interest through subsidiary (as a percent)     15.00%              
Membership units (in shares)     5.3              
Value of membership units     $ 2,300              
PSCI | Class B Membership Interests | PharmaPoint                    
Schedule of Equity Method Investments [Line Items]                    
Ownership interest through subsidiary (as a percent)             28.00%   28.00%  
Membership units (in shares)       5.0     5.0   5.0  
PSCI | Class B Membership Interests | Nations Pharmaceuticals, LLC                    
Schedule of Equity Method Investments [Line Items]                    
Ownership interest through subsidiary (as a percent)             72.00%      
PSCI | Class A Membership Interests | Nations Pharmaceuticals, LLC                    
Schedule of Equity Method Investments [Line Items]                    
Membership units (in shares)       13.0     13.0